+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
ID05860868

Comparing Two vs Three Cycles of Induction Chemotherapy with Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma Stage T1-4N2-3

Led by First Affiliated Hospital, Sun Yat-Sen University · Updated on 2023-05-16

474

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether 2 cycles of induction chemotherapy combined with concurrent chemoradiotherapy is not worse than 3 cycles of induction chemotherapy combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma. This phase III clinical trial focuses on adults aged 18 to 65 years with specific stages of nasopharyngeal carcinoma who have not previously received anti-cancer treatment. The study aims to determine if fewer chemotherapy cycles can provide similar outcomes in this patient group. The trial compares two treatment approaches one group receives 2 cycles of induction chemotherapy, and the other receives 3 cycles, both followed by concurrent chemoradiotherapy. Induction chemotherapy regimens include TP docetaxel and cisplatin, TPF docetaxel, cisplatin, and 5-fluorouracil, or GP gemcitabine and cisplatin, administered every three weeks. Concurrent chemotherapy uses cisplatin every three weeks, combined with definitive radiotherapy given once daily, five days a week, at a dose of 66-70 Gy. Participants will be monitored for treatment effects and outcomes over time, focusing primarily on failure-free survival at three years. Researchers will assess how well the treatments work in controlling the cancer without distant spread. Participants will undergo routine evaluations to track their health status, treatment adherence, and any side effects. The total study duration spans several years to capture long-term results and safety data.

CONDITIONS

Brief Title

Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma

Research Team

C

Cheng-Tao Wang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here